Sign Up to like & get
recommendations!
1
Published in 2022 at "Bioconjugate chemistry"
DOI: 10.1021/acs.bioconjchem.2c00316
Abstract: The pentasaccharide Fondaparinux, a synthetic selective factor Xa inhibitor, is one of the safest anticoagulants in the heparin family that is recommended as an alternative drug for patients with hypersensitivity to other drugs such as…
read more here.
Keywords:
fondaparinux;
microscopy;
concentration;
thrombocytopenia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000012236
Abstract: Rationale: Fondaparinux, as a factor Xa-inhibitor, is used off label to manage heparin-induced thrombocytopenia (HIT), but little experience with HIT patients has been reported in the literature. Moreover, the use of fondaparinux for full anticoagulation…
read more here.
Keywords:
fondaparinux;
heparin;
ill patient;
induced thrombocytopenia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14642
Abstract: Sepsis triggers dysfunction of coagulation and fibrinolytic systems leading to disseminated intravascular coagulation (DIC) that contributes to organ failure and death. Fondaparinux (FPX) is a synthetic pentasaccharide that binds to antithrombin (AT) and selectively inhibits…
read more here.
Keywords:
sepsis;
fondaparinux;
pentasaccharide reduces;
fondaparinux pentasaccharide ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020955029
Abstract: Objective: The objective of this study is to comprehensively review the efficacy and safety data of low-molecular-weight heparins (LMWHs) and fondaparinux in pediatric patients with obesity. Data Sources: A comprehensive literature search of PubMed, SCOPUS,…
read more here.
Keywords:
low molecular;
fondaparinux;
patients obesity;
molecular weight ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms26094045
Abstract: Glycosaminoglycans (GAGs) are key ligands for proteins involved in physiological and pathological processes. Specific GAG-binding patterns are rarely identified, with the heparin pentasaccharide as an Antithrombin-III ligand being the best characterized. Generating glycan-specific antibodies is…
read more here.
Keywords:
high affinity;
heparin pentasaccharide;
vnar;
fondaparinux ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Arquivos Brasileiros de Cardiologia"
DOI: 10.36660/abc.20230793
Abstract: Resumo Fundamento O fondaparinux é um anticoagulante eficaz e seguro usado no tratamento de síndromes coronarianas agudas (SCAs). No entanto, devido à baixa representatividade de indivíduos obesos em ensaios clínicos, os efeitos de se aplicar…
read more here.
Keywords:
foi;
enoxaparina tratamento;
obesos com;
fondaparinux enoxaparina ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Arquivos Brasileiros de Cardiologia"
DOI: 10.36660/abc.20240329
Abstract: Resumo Fundamento: Tanto o fondaparinux quanto o acesso radial têm sido associados a menores taxas de eventos adversos cardiovasculares maiores (MACE) em pacientes com síndrome coronariana aguda (SCA). Objetivo: Avaliar a associação entre o uso…
read more here.
Keywords:
uso fondaparinux;
com;
foi;
acesso radial ... See more keywords